Clostridium butyricum combined with bifidobacterium infantis probiotic mixture restores fecal microbiota and attenuates systemic inflammation in mice with antibiotic-associated diarrhea

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Li, Lanjuan ^a   Ling, Zongxin ^a   Liu, Xia ^a,b   Cheng, Yiwen ^a   Luo, Yueqiu ^a   Yuan, Li ^a   Xiang, Charlie ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIFIDOBACTERIUM INFANTIS PROBIOTIC AGENT; CLOSTRIDIUM BUTYRICUM PROBIOTIC AGENT; GAMMA INTERFERON; INTERLEUKIN 10; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ARTICLE; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; CLOSTRIDIUM BUTYRICUM; COLON; CONTROLLED STUDY; DRUG EFFICACY; FECES MICROFLORA; HISTOPATHOLOGY; INFLAMMATION; INTESTINE FLORA; MALE; MOUSE; NONHUMAN; ANIMAL; BACTERIAL LOAD; BIFIDOBACTERIUM; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; DENATURING GRADIENT GEL ELECTROPHORESIS; DIARRHEA; DRUG EFFECTS; FECES; MICROBIOLOGY; MICROFLORA; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

BIFIDOBACTERIUM LONGUM BV. INFANTIS; CLOSTRIDIUM BUTYRICUM; MUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; BIFIDOBACTERIUM; CLOSTRIDIUM BUTYRICUM; COLON; CYTOKINES; DENATURING GRADIENT GEL ELECTROPHORESIS; DIARRHEA; FECES; INFLAMMATION; MALE; MICE, INBRED C57BL; MICROBIOTA; POLYMERASE CHAIN REACTION; PROBIOTICS;

EID: 84924567159     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/582048     Document Type: Article

References (66)

1. L. V. McFarland, "Antibiotic-associated diarrhea: epidemiology, trends and treatment," Future Microbiology, Vol. 3, no. 5, pp. 563-578, 2008.
2. Z. Ling, X. Liu, X. Jia et al., "Impacts of infection with different toxigenic Clostridium dificile strains on faecal microbiota in children," Scientific Reports, Vol. 4, article 7485, 2014.
3. C. Jernberg, S. Löfmark, C. Edlund, and J. K. Jansson, "Longterm impacts of antibiotic exposure on the human intestinal microbiota," Microbiology, Vol. 156, no. 11, pp. 3216-3223, 2010.
4. I. Sekirov, N. M. Tam, M. Jogova et al., "Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection," Infection and Immunity, Vol. 76, no. 10, pp. 4726-4736, 2008.
5. M. Li, W. H. Li, S. Wen, Y. H. Liu, and L. Tang, "Effects of ceftriaxone-induced intestinal dysbacteriosis on dendritic cells of small intestine in mice," Microbiology and Immunology, Vol. 57, no. 8, pp. 561-568, 2013.
6. F. Gao, M. Li, Y. H. Liu, C. Gao, S. Wen, and L. Tang, "Intestinal dysbacteriosis induces changes of T lymphocyte subpopulations in Peyer's patches of mice and orients the immune response towards humoral immunity," Gut Pathogens, Vol. 4, no. 1, article 19, 2012.
7. J. K. Nicholson, E. Holmes, and I. D. Wilson, "Gut microorganisms, mammalian metabolism and personalized health care," Nature Reviews Microbiology, Vol. 3, no. 5, pp. 431-438, 2005.
8. J. A. Vanderhoof, D. B. Whitney, D. L. Antonson, T. L. Hanner, J. V. Lupo, and R. J. Young, "Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children," Journal of Pediatrics, Vol. 135, no. 5, pp. 564-568, 1999.
9. L. V. McFarland, "Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium dificile disease," American Journal of Gastroenterology, Vol. 101, no. 4, pp. 812-822, 2006.
10. H. M. Hamer, D. Jonkers, K. Venema, S. Vanhoutvin, F. J. Troost, and R.-J. Brummer, "Review article: the role of butyrate on colonic function," Alimentary Pharmacology & Therapeutics, Vol. 27, no. 2, pp. 104-119, 2008.
11. J. B. Ewaschuk, H. Diaz, L. Meddings et al., "Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function," The American Journal of Physiology-Gastrointestinal and Liver Physiology, Vol. 295, no. 5, pp. G1025-G1034, 2008.
12. Z. Ling, J. Kong, P. Jia et al., "Analysis of oral microbiota in children with dental caries by PCR-DGGE and barcoded pyrosequencing," Microbial Ecology, Vol. 60, no. 3, pp. 677-690, 2010.
13. Z. Ling, J. Kong, F. Liu et al., "Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis," BMC Genomics, Vol. 11, no. 1, article 488, 2010.
14. G. Muyzer, E. C. de Waal, and A. G. Uitterlinden, "Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA," Applied and Environmental Microbiology, Vol. 59, no. 3, pp. 695-700, 1993.
15. S. Bartosch, A. Fite, G. T. Macfarlane, and M. E. T. McMurdo, "Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota," Applied and Environmental Microbiology, Vol. 70, no. 6, pp. 3575-3581, 2004.
16. Y. Chen, F. Yang, H. Lu et al., "Characterization of fecal micro-bial communities in patients with liver cirrhosis," Hepatology, Vol. 54, no. 2, pp. 562-572, 2011.
17. B. O. Adamu and T. D. Lawley, "Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium dificile infection," Current Opinion in Microbiology, Vol. 16, no. 5, pp. 596-601, 2013.
18. T. D. Lawley and A. W. Walker, "Intestinal colonization resistance," Immunology, Vol. 138, no. 1, pp. 1-11, 2013.
19. L. V. McFarland, "Epidemiology, risk factors and treatments for antibiotic-associated diarrhea," Digestive Diseases, Vol. 16, no. 5, pp. 292-307, 1998.
20. R. S. Beniwal, V. C. Arena, L. Thomas et al., "A randomized trial of yogurt for prevention of antibiotic-associated diarrhea," Digestive Diseases and Sciences, Vol. 48, no. 10, pp. 2077-2082, 2003.
21. L. V. McFarland, "Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium dificile infections," Anaerobe, Vol. 15, no. 6, pp. 274-280, 2009.
22. M. Takahashi, H. Taguchi, H. Yamaguchi, T. Osaki, A. Komatsu, and S. Kamiya, "The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice," FEMS Immunology and Medical Microbiology, Vol. 41, no. 3, pp. 219-226, 2004.
23. Q. Kong, G.-Q. He, J.-L. Jia, Q.-L. Zhu, and H. Ruan, "Oral administration of Clostridium butyricum for modulating gastrointestinal microflora in mice," Current Microbiology, Vol. 62, no. 2, pp. 512-517, 2011.
24. C. M. Yang, G. T. Cao, P. R. Ferket et al., "Effects of probiotic, Clostridium butyricum, on growth performance, immune function, and cecal microflora in broiler chickens," Poultry Science, Vol. 91, no. 9, pp. 2121-2129, 2012.
25. P. Courvalin, "Antibiotic resistance: the pros and cons of probiotics," Digestive and Liver Disease, Vol. 38, supplement 2, pp. S261-S265, 2006.
26. P. J. Whorwell, L. Altringer, J. Morel et al., "Eficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome," The American Journal of Gastroenterology, Vol. 101, no. 7, pp. 1581-1590, 2006.
27. B. Zhang, X. Yang, Y. Guo, and F. Long, "Effects of dietary lipids and Clostridium butyricum on the performance and the digestive tract of broiler chickens," Archives of Animal Nutrition, Vol. 65, no. 4, pp. 329-339, 2011.
28. K. Imase, M. Takahashi, A. Tanaka et al., "Eficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota," Microbiology and Immunology, Vol. 52, no. 3, pp. 156-161, 2008.
29. L. Macia, A. N. Thorburn, L. C. Binge et al., "Microbial influ-ences on epithelial integrity and immune function as a basis for inflammatory diseases," Immunological Reviews, Vol. 245, no. 1, pp. 164-176, 2012.
30. J. L. Round and S. K. Mazmanian, "The gut microbiota shapes intestinal immune responses during health and disease," Nature Reviews Immunology, Vol. 9, no. 5, pp. 313-323, 2009.
31. J. M. W. Wong, R. De Souza, C. W. C. Kendall, A. Emam, and D. J. A. Jenkins, "Colonic health: fermentation and short chain fatty acids," Journal of Clinical Gastroenterology, Vol. 40, no. 3, pp. 235-243, 2006.
32. A. Hayashi, T. Sato, N. Kamada et al., "A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice," Cell Host and Microbe, Vol. 13, no. 6, pp. 711-722, 2013.
33. N. Osman, D. Adawi, G. Molin, S. Ahrne, A. Berggren, and B. Jeppsson, "Bifidobacterium infantis strains with and without a combination of Oligofructose and Inulin (OFI) attenuate inflammation in DSS-induced colitis in rats," BMC Gastroenterology, Vol. 6, article 31, 2006.
34. L. V. McFarland, "Antibiotic-associated diarrhea: epidemiology, trends and treatment," Future Microbiology, Vol. 3, no. 5, pp. 563-578, 2008.
35. Z. Ling, X. Liu, X. Jia et al., "Impacts of infection with different toxigenic Clostridium dificile strains on faecal microbiota in children," Scientific Reports, Vol. 4, article 7485, 2014.
36. C. Jernberg, S. Löfmark, C. Edlund, and J. K. Jansson, "Longterm impacts of antibiotic exposure on the human intestinal microbiota," Microbiology, Vol. 156, no. 11, pp. 3216-3223, 2010.
37. I. Sekirov, N. M. Tam, M. Jogova et al., "Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection," Infection and Immunity, Vol. 76, no. 10, pp. 4726-4736, 2008.
38. M. Li, W. H. Li, S. Wen, Y. H. Liu, and L. Tang, "Effects of ceftriaxone-induced intestinal dysbacteriosis on dendritic cells of small intestine in mice," Microbiology and Immunology, Vol. 57, no. 8, pp. 561-568, 2013.
39. F. Gao, M. Li, Y. H. Liu, C. Gao, S. Wen, and L. Tang, "Intestinal dysbacteriosis induces changes of T lymphocyte subpopulations in Peyer's patches of mice and orients the immune response towards humoral immunity," Gut Pathogens, Vol. 4, no. 1, article 19, 2012.
40. J. K. Nicholson, E. Holmes, and I. D. Wilson, "Gut microorganisms, mammalian metabolism and personalized health care," Nature Reviews Microbiology, Vol. 3, no. 5, pp. 431-438, 2005.
41. J. A. Vanderhoof, D. B. Whitney, D. L. Antonson, T. L. Hanner, J. V. Lupo, and R. J. Young, "Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children," Journal of Pediatrics, Vol. 135, no. 5, pp. 564-568, 1999.
42. L. V. McFarland, "Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium dificile disease," American Journal of Gastroenterology, Vol. 101, no. 4, pp. 812-822, 2006.
43. H. M. Hamer, D. Jonkers, K. Venema, S. Vanhoutvin, F. J. Troost, and R.-J. Brummer, "Review article: the role of butyrate on colonic function," Alimentary Pharmacology & Therapeutics, Vol. 27, no. 2, pp. 104-119, 2008.
44. J. B. Ewaschuk, H. Diaz, L. Meddings et al., "Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function," The American Journal of Physiology-Gastrointestinal and Liver Physiology, Vol. 295, no. 5, pp. G1025-G1034, 2008.
45. Z. Ling, J. Kong, P. Jia et al., "Analysis of oral microbiota in children with dental caries by PCR-DGGE and barcoded pyrosequencing," Microbial Ecology, Vol. 60, no. 3, pp. 677-690, 2010.
46. Z. Ling, J. Kong, F. Liu et al., "Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis," BMC Genomics, Vol. 11, no. 1, article 488, 2010.
47. G. Muyzer, E. C. de Waal, and A. G. Uitterlinden, "Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA," Applied and Environmental Microbiology, Vol. 59, no. 3, pp. 695-700, 1993.
48. S. Bartosch, A. Fite, G. T. Macfarlane, and M. E. T. McMurdo, "Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota," Applied and Environmental Microbiology, Vol. 70, no. 6, pp. 3575-3581, 2004.
49. Y. Chen, F. Yang, H. Lu et al., "Characterization of fecal micro-bial communities in patients with liver cirrhosis," Hepatology, Vol. 54, no. 2, pp. 562-572, 2011.
50. B. O. Adamu and T. D. Lawley, "Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium dificile infection," Current Opinion in Microbiology, Vol. 16, no. 5, pp. 596-601, 2013.
51. T. D. Lawley and A. W. Walker, "Intestinal colonization resistance," Immunology, Vol. 138, no. 1, pp. 1-11, 2013.
52. L. V. McFarland, "Epidemiology, risk factors and treatments for antibiotic-associated diarrhea," Digestive Diseases, Vol. 16, no. 5, pp. 292-307, 1998.
53. R. S. Beniwal, V. C. Arena, L. Thomas et al., "A randomized trial of yogurt for prevention of antibiotic-associated diarrhea," Digestive Diseases and Sciences, Vol. 48, no. 10, pp. 2077-2082, 2003.
54. L. V. McFarland, "Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium dificile infections," Anaerobe, Vol. 15, no. 6, pp. 274-280, 2009.
55. M. Takahashi, H. Taguchi, H. Yamaguchi, T. Osaki, A. Komatsu, and S. Kamiya, "The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice," FEMS Immunology and Medical Microbiology, Vol. 41, no. 3, pp. 219-226, 2004.
56. Q. Kong, G.-Q. He, J.-L. Jia, Q.-L. Zhu, and H. Ruan, "Oral administration of Clostridium butyricum for modulating gastrointestinal microflora in mice," Current Microbiology, Vol. 62, no. 2, pp. 512-517, 2011.
57. C. M. Yang, G. T. Cao, P. R. Ferket et al., "Effects of probiotic, Clostridium butyricum, on growth performance, immune function, and cecal microflora in broiler chickens," Poultry Science, Vol. 91, no. 9, pp. 2121-2129, 2012.
58. P. Courvalin, "Antibiotic resistance: the pros and cons of probiotics," Digestive and Liver Disease, Vol. 38, supplement 2, pp. S261-S265, 2006.
59. P. J. Whorwell, L. Altringer, J. Morel et al., "Eficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome," The American Journal of Gastroenterology, Vol. 101, no. 7, pp. 1581-1590, 2006.
60. B. Zhang, X. Yang, Y. Guo, and F. Long, "Effects of dietary lipids and Clostridium butyricum on the performance and the digestive tract of broiler chickens," Archives of Animal Nutrition, Vol. 65, no. 4, pp. 329-339, 2011.
61. K. Imase, M. Takahashi, A. Tanaka et al., "Eficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota," Microbiology and Immunology, Vol. 52, no. 3, pp. 156-161, 2008.
62. L. Macia, A. N. Thorburn, L. C. Binge et al., "Microbial influ-ences on epithelial integrity and immune function as a basis for inflammatory diseases," Immunological Reviews, Vol. 245, no. 1, pp. 164-176, 2012.
63. J. L. Round and S. K. Mazmanian, "The gut microbiota shapes intestinal immune responses during health and disease," Nature Reviews Immunology, Vol. 9, no. 5, pp. 313-323, 2009.
64. J. M. W. Wong, R. De Souza, C. W. C. Kendall, A. Emam, and D. J. A. Jenkins, "Colonic health: fermentation and short chain fatty acids," Journal of Clinical Gastroenterology, Vol. 40, no. 3, pp. 235-243, 2006.
65. A. Hayashi, T. Sato, N. Kamada et al., "A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice," Cell Host and Microbe, Vol. 13, no. 6, pp. 711-722, 2013.
66. N. Osman, D. Adawi, G. Molin, S. Ahrne, A. Berggren, and B. Jeppsson, "Bifidobacterium infantis strains with and without a combination of Oligofructose and Inulin (OFI) attenuate inflammation in DSS-induced colitis in rats," BMC Gastroenterology, Vol. 6, article 31, 2006.